Do you want to read an article? Please log in or register.
Restless legs-like syndrome as an emergent adverse event of CGRP monoclonal antibodies: A report of two cases
Migraine and Headache
Related content
Multiple Sclerosis
Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database
Mult Scler.
Caldito NG, Shirani A, Salter A, Stuve O
doi: 10.1177/1352458520949986.
Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology.
Winkelman JW, Armstrong MJ, Allen RP, Chaudhuri KR, Ondo W, Trenkwalder C, Zee PC, Gronseth GS, Gloss D, Zesiewicz T
Migraine and Headache
Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
Eur J Cancer.
Cuzzubbo S, Javeri F, Tissier M, Roumi A, Barlog C, Doridam J, Lebbe C, Belin C, Ursu R, Carpentier AF
doi: 10.1016/j.ejca.2016.12.001.
Further Publications NeurologyFurther Publications Psychiatry
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System
Psychother Psychosom.
Gastaldon C, Raschi E, Kane JM, Barbui C, Schoretsanitis G
doi: 10.1159/000510703.
Alzheimer’s Disease
Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: a systematic review and meta-analysis of phase III RCTs in Alzheimer's disease
Ageing Res Rev
Avgerinos KI, Ferrucci L, Kapogiannis D
doi: 10.1016/j.arr.2021.101339
Migraine and Headache
Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis
Cephalalgia
Drellia K, Kokoti L, Deligianni CI, Papadopoulos D, Mitsikostas DD
doi: 10.1177/0333102421989601
Multiple Sclerosis
Monoclonal Antibodies for Multiple Sclerosis: An Update
BioDrugs.
Graf J, Aktas O, Rejdak K, Hartung HP
doi: 10.1007/s40259-
Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: Nested case-control study
Neurology.
Sodhi M, Sheldon CA, Carleton B, Etminan M
doi: 10.1212/
RECOMMENDED
Further Publications NeurologyFurther Publications Psychiatry
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study
★ 2
Recommended by
Prof. Dr Christian Kamm, Faculty Member
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Lancet Neurol.
Armangue T, Olivé-Cirera G, Martínez-Hernandez E, Sepulveda M, Ruiz-Garcia R, Muñoz-Batista M, Ariño H, González-Álvarez V, Felipe-Rucián A, Jesús Martínez-González M, Cantarín-Extremera V, Concepción Miranda-Herrero M, Monge-Galindo L, Tomás-Vila M, Miravet E, Málaga I, Arrambide G, Auger C, Tintoré M, Montalban X, Vanderver A, Graus F, Saiz A, Dalmau J, Spanish Pediatric anti-MOG Study Group.
doi: 10.1016/S1474-4422(19)30488-0.